分享到
Mice Transgenic for Equine Cyclin T1 and ELR1 are Susceptible to Equine Infectious Anemia Virus Infection
The research team led by Dr Wang Xiaojun at the Harbin Veterinary Research Institute (HVRI) constructed for the first time a novel fully transgenic mouse with equine cyclin T1 and ELR1 genes (ELR1/eCT1 mice) that supports in vivo replication of equine infectious anemia virus (EIAV), and the transgenic mice may provide an alternative in vivo infection model that is highly reproducible and inexpensive for studying EIAV.
As a member of the tumor necrosis factor receptor (TNFR) protein superfamily, equine lentivirus receptor 1 (ELR1) has been shown to be expressed in various equine cells that are permissive for equine infectious anemia virus (EIAV) replication. The EIAV Tat protein (eTat) activates transcription initiated at the viral long terminal repeat (LTR) promoter through a unique mechanism that requires the recruitment of the equine cyclin T1 (eCT1) cofactor into the viral TAR RNA target element.
According to Dr. Wang Xiaojun, the head of the research team of equine infectious diseases and lentivirus infection at the HVRI, in vitro studies have demonstrated that mouse fibroblast cell lines (e.g., NIH 3T3 cells) that express the EIAV receptor ELR1 and eCT1 support the productive replication of EIAV, but it was unclear whether the introduction of these two genes into the mice may result in a permissive environment for EIAV infection and replication in vivo.
For answering this question, Dr. Wang Xiaojun’s team constructed mice transgenic for ELR1 and eCT1, and the results of the related experiments have showed that the transgenic mice are susceptible to EIAV infection and replication. Further, EIAV infection can cause lesions on the spleen and lymph nodes, similar to those frequently observed in horses, the natural hosts. Therefore, ELR1 and eCT1 are essential in vivo for EIAV invasion and replication.
In addition, because it is more expensive to use horses in animal experiments and horse-related antibodies and reagents are not easily obtained, ELR1/eCT1 mice may provide an alternative in vivo infection model for evaluating the effectiveness of candidate EIAV vaccines and for studying the pathobiology of EIAV infection.
More information are available on: http://www.retrovirology.com/content/12/1/36
According to Dr. Wang Xiaojun, the head of the research team of equine infectious diseases and lentivirus infection at the HVRI, in vitro studies have demonstrated that mouse fibroblast cell lines (e.g., NIH 3T3 cells) that express the EIAV receptor ELR1 and eCT1 support the productive replication of EIAV, but it was unclear whether the introduction of these two genes into the mice may result in a permissive environment for EIAV infection and replication in vivo.
For answering this question, Dr. Wang Xiaojun’s team constructed mice transgenic for ELR1 and eCT1, and the results of the related experiments have showed that the transgenic mice are susceptible to EIAV infection and replication. Further, EIAV infection can cause lesions on the spleen and lymph nodes, similar to those frequently observed in horses, the natural hosts. Therefore, ELR1 and eCT1 are essential in vivo for EIAV invasion and replication.
In addition, because it is more expensive to use horses in animal experiments and horse-related antibodies and reagents are not easily obtained, ELR1/eCT1 mice may provide an alternative in vivo infection model for evaluating the effectiveness of candidate EIAV vaccines and for studying the pathobiology of EIAV infection.
More information are available on: http://www.retrovirology.com/content/12/1/36
Latest News
-
Apr 18, 2024Opening Ceremony of the Training Workshop on Wheat Head Scab Resistance Breeding and Pest Control in Africa Held in CAAS -
Apr 03, 2024IPPCAAS Co-organized the Training Workshop on Management and Application of Biopesticides in Nepal -
Mar 28, 2024Delegation from the School of Agriculture and Food Science of University College Dublin, Ireland Visit to IAS, CAAS -
Mar 25, 2024Director of World Food Prize Foundation visited GSCAAS -
Mar 20, 2024Institute of Crop Sciences (ICS) and Syngenta Group Global Seeds Advance Collaborative Research in the Seed Industry